ZA885998B - 2-oxo-1-((substituted sulfonyl)amino)carbonyl)-azetidines - Google Patents

2-oxo-1-((substituted sulfonyl)amino)carbonyl)-azetidines

Info

Publication number
ZA885998B
ZA885998B ZA885998A ZA885998A ZA885998B ZA 885998 B ZA885998 B ZA 885998B ZA 885998 A ZA885998 A ZA 885998A ZA 885998 A ZA885998 A ZA 885998A ZA 885998 B ZA885998 B ZA 885998B
Authority
ZA
South Africa
Prior art keywords
azetidines
oxo
carbonyl
amino
substituted sulfonyl
Prior art date
Application number
ZA885998A
Other languages
English (en)
Inventor
William Allen Slusarchyk
Allen Slusarchyk William
Peter Hans Ermann
Hans Ermann Peter
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA885998B publication Critical patent/ZA885998B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA885998A 1987-08-13 1988-08-12 2-oxo-1-((substituted sulfonyl)amino)carbonyl)-azetidines ZA885998B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/085,050 US4777252A (en) 1987-08-13 1987-08-13 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines

Publications (1)

Publication Number Publication Date
ZA885998B true ZA885998B (en) 1989-04-26

Family

ID=22189148

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885998A ZA885998B (en) 1987-08-13 1988-08-12 2-oxo-1-((substituted sulfonyl)amino)carbonyl)-azetidines

Country Status (8)

Country Link
US (1) US4777252A (xx)
EP (1) EP0303286A1 (xx)
JP (1) JPH0196181A (xx)
AU (1) AU2091988A (xx)
DK (1) DK454188A (xx)
HU (1) HU201547B (xx)
NZ (1) NZ225821A (xx)
ZA (1) ZA885998B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02502455A (ja) * 1987-02-27 1990-08-09 ジ・アップジョン・カンパニー ピリドンカルボン酸または酸誘導体を含有する抗生物質β‐ラクタム
US4904775A (en) * 1988-05-16 1990-02-27 E. R. Squibb & Sons, Inc. Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics
FR2653429B1 (fr) * 1989-10-25 1991-12-20 Adir Nouveaux derives de l'azetidin-2-one, 1,3,4-trisubstitues, intermediaires utiles pour la synthese des beta-lactames, et leur procede de synthese asymetrique.
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
IL99658A0 (en) * 1990-10-15 1992-08-18 Merck & Co Inc Substituted azetidinones and pharmaceutical compositions containing them
CA2309882A1 (en) * 1997-12-22 1999-07-01 Pharmacia & Upjohn Company 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
AU4818000A (en) * 1999-05-06 2000-11-21 Neurogen Corporation Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
CA2445697A1 (en) * 2001-04-26 2002-11-07 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
LT2502911T (lt) 2004-06-24 2017-09-11 Vertex Pharmaceuticals Incorporated Atp surišančios kasetės transporterių moduliatoriai
US8354427B2 (en) * 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
JP2006131568A (ja) * 2004-11-08 2006-05-25 Ueno Seiyaku Oyo Kenkyusho:Kk ヒドロキシナフトエ酸ヒドラジドおよびその誘導体ならびにその製造方法
US20090105272A1 (en) * 2005-12-24 2009-04-23 Grootenhuis Peter D J Prodrugs of modulators of ABC transporters
PT3219705T (pt) 2005-12-28 2020-05-20 Vertex Pharma Composições farmacêuticas da forma amorfa de n-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4-di-hidro-4-oxoquinolina-3-carboxamida
CA2744756C (en) 2008-12-19 2013-05-28 Pfizer Inc. Monocarbams and their use as antibacterial agent
EP2821400B1 (en) 2009-03-20 2017-09-27 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
JP5806672B2 (ja) 2009-10-30 2015-11-10 ドメイン・セラピューティクス 新規オキシム誘導体及び代謝型グルタミン酸受容体のアロステリック調節因子としての利用
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
IL265430B2 (en) 2012-02-27 2024-08-01 Vertex Pharma Pharmaceutical preparations containing a solid dispersion of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide and uses thereof
DK3186257T3 (en) 2014-08-27 2019-04-01 Prexton Therapeutics Sa Hitherto UNKNOWN CHROMONOXIME DERIVATIVE AND ITS USE AS AN ALLOSTERIC MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS
KR20170063954A (ko) 2014-10-07 2017-06-08 버텍스 파마슈티칼스 인코포레이티드 낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정
MA42700B1 (fr) 2015-08-27 2019-12-31 Prexton Therapeutics Sa Dérivé d'oxime de chromone et son utilisation comme modulateur allostérique de récepteurs métabotropiques du glutamate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
US4587047A (en) * 1981-04-09 1986-05-06 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
JPH01502660A (ja) * 1986-05-23 1989-09-14 ジ・アップジョン・カンパニー N―1置換スルホニルアミノカルボニル、c―4置換モノバクタム類
US4801705A (en) * 1986-06-23 1989-01-31 E. R. Squibb & Sons, Inc. 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines

Also Published As

Publication number Publication date
HU201547B (en) 1990-11-28
DK454188A (da) 1989-02-14
HUT48235A (en) 1989-05-29
AU2091988A (en) 1989-02-16
EP0303286A1 (en) 1989-02-15
JPH0196181A (ja) 1989-04-14
NZ225821A (en) 1990-11-27
US4777252A (en) 1988-10-11
DK454188D0 (da) 1988-08-12

Similar Documents

Publication Publication Date Title
ZA885998B (en) 2-oxo-1-((substituted sulfonyl)amino)carbonyl)-azetidines
IL86700A0 (en) Polypeptides
AU6315686A (en) 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)-azetidines
PH25327A (en) Binfunctional proteins
EP0315367A3 (en) Polypeptides
JPS6429353A (en) Sulfonyl polyenes
GB2206352B (en) Polypeptides
GB8724412D0 (en) Protein
GB8702171D0 (en) Protein hydrolysates
PH21695A (en) 2-oxo-1-(aminocarbonylamino sulfonyl amino carbonyl)azetidines
EP0349569A4 (en) BEEF INTERLEUKIN 1 g (b).
GB8817160D0 (en) Novel proteins
JPS6426577A (en) 2-oxo-1-(((substituted sulfonyl)amino)carbonyl) azetidines
JPS6416798A (en) Peptide
JPS646295A (en) Anf-active peptide
AU2735888A (en) 2-oxo-1-((substituted sulfonyl)amino)carbonyl)-azetidiness
GB8815318D0 (en) 2-oxo-1-(substituted sulfonyl)amino-carbonyl azetidines
GB8713559D0 (en) Structural proteins
GB8712191D0 (en) Block for assembly toy
GB8921172D0 (en) Proteins
IE872995L (en) Polypeptide
ZA884655B (en) Polypeptides
GB8725598D0 (en) Polypeptides
IE862835L (en) Protein modification
IE871890L (en) Protein immunotoxins